The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma.
New clinical trial results show that adding rituximab to standard chemotherapy could improve survival for some children with non-Hodgkin lymphoma.
A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.
A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England.
An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England.
Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.
Using a test that measures gene activity could help to tailor treatment for some women with early stage breast cancer, new research suggests.
Guest author, Dr Rosanna Jackson, outlines what scientists are doing to make treatment for one type of childhood leukaemia kinder.